- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07914452
Personalized Routine and Habit Integration to Support Medication Management (PRISM)
A Randomized Controlled Trial of the Personalized Routine and Habit Integration to Support Medication Management Intervention (PRISM)
The objective of this study is to test a multidisciplinary care team behavioral intervention to enhance medication adherence among older adults with multiple chronic conditions (MCC). The Personalized Routine and Habit Integration to Support Medication Management (PRISM) intervention is a novel, scalable intervention delivered by pharmacists and occupational therapists (OTs) that aims to improve medication adherence by reducing regimen complexity and solidifying medication habits within daily routines. The goal of this randomized control trial is to evaluate the effectiveness and implementation of PRISM compared with enhanced usual care.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Julie Lauffenburger, PharmD, PhD
- Telefonnummer: 857-282-1962
- E-post: jlauffenburger@bwh.harvard.edu
Studiesteder
-
-
Massachusetts
-
Somerville, Massachusetts, Forente stater, 021250
- Mass General Brigham
-
Ta kontakt med:
- Julie Lauffenburger, PharmD, PhD
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- appointment in the past 18 months in the Galter-18 primary care practice
- ≥2 cardiovascular and/or metabolic chronic conditions documented in the EHR,
- ≥5 daily medications
- poor medication adherence ≥1 cardiovascular and/or metabolic medication using validated EHR-data algorithms
- English-speaking
- ≥65 years old
Exclusion Criteria:
- severe mental illness
- dementia
- dependent on others for medication management
- have received a pharmacist-led comprehensive medication review in the last 6 months
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Helsetjenesteforskning
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: PRISM Arm
The PRISM arm will receive three sessions: 1) comprehensive medication management session with a clinical pharmacist, 2) an in-home visit with an occupational therapist (OT), and then 3) follow up phone call with OT. |
The PRISM arm will receive three sessions: 1) comprehensive medication management session with a clinical pharmacist, 2) an in-home visit with an occupational therapist (OT), and then 3) follow up phone call with OT. |
|
Eksperimentell: Enhanced usual care (EUC) arm
The EUC arm will receive a comprehensive medication management session with a clinical pharmacist. |
The EUC arm will receive a comprehensive medication management session with a clinical pharmacist. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
PDC (Continuous) - Cardiometabolic
Tidsramme: Through 6-months post-baseline
|
Medication adherence to cardio-metabolic pill-form daily medications including the following classes: ACE inhibitor, Angiotensin Receptor Blockers (ARBs), Beta-Blockers, Calcium Channel Blockers, Diuretics, Lipid-lowering, Metformin |
Through 6-months post-baseline
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
PDC (Continuous) - All
Tidsramme: Through 6-months post-baseline
|
Medication adherence to all daily prescription pill-form medications |
Through 6-months post-baseline
|
|
PDC (Continuous) - Study-entering
Tidsramme: Through 6-months post-baseline
|
Medication adherence to study-entering medication i.e. the medciation that was identified during the eligibility screening process as having poor medication adherence. |
Through 6-months post-baseline
|
|
Medication Adherence Report Scale 10-item (MARS-10)
Tidsramme: Through 3-months post-baseline
|
Self reported; medication ahderence to all prescriptoin daily medications |
Through 3-months post-baseline
|
|
Regimen Knowledge (continuous)
Tidsramme: Through 3-months post-baseline
|
Participant knowledge of prescribed medications, including their purpose, dosage, and administration instructions using Medication Purpose & Dosage Identification Score (MPDS). |
Through 3-months post-baseline
|
|
Regimen Complexity (continuous)
Tidsramme: Through 3-months post-baseline
|
Complexity of the participant's prescribed medication regime using Medication Regimen Complexity Index (MRCI). |
Through 3-months post-baseline
|
|
Daily Routine (continuous)
Tidsramme: Through 3-months post-baseline
|
Daily activity patterns and routines, including the timing of activities throughout the day using a time diary. |
Through 3-months post-baseline
|
|
Medication Habits (continuous)
Tidsramme: Through 3-months post-baseline
|
The extent to which medication-taking is performed automatically as a habitual behavior using Self-Report Behavioral Automaticity Index (SRBAI). |
Through 3-months post-baseline
|
|
Problem Solving Skills (continuous)
Tidsramme: Through 3-months post-baseline
|
Participant ability to identify, address, and learn from problems affecting medication-taking and health management using Health Problem-Solving Scale (HPSS). |
Through 3-months post-baseline
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 2026P001972
- 5P30AG064199-08 (U.S. NIH-stipend/kontrakt)
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .